FERMT2 (also known as Kindlin-2), a focal adhesion protein, has been found to regulate cancer cell proliferation, apoptosis, and chromosomal abnormalities in breast cancer that are associated with tumor stromal invasion, lymph node metastasis, and patient outcome in gastric cancer. This evidence concerns the gene FERMT2 and breast cancer.